NurExone Biologic Inc. (TSXV:NRX)
0.7000
-0.0100 (-1.41%)
At close: Nov 28, 2025
| Market Cap | 63.48M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -9.10M |
| Shares Out | 90.68M |
| EPS (ttm) | -0.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 51,000 |
| Average Volume | 32,684 |
| Open | 0.7000 |
| Previous Close | 0.7100 |
| Day's Range | 0.7000 - 0.7000 |
| 52-Week Range | 0.5400 - 1.1400 |
| Beta | 0.23 |
| RSI | 40.79 |
| Earnings Date | Nov 28, 2025 |